%0 Journal Article
%T First line PD-1 inhibitor, Serplulimab Plus Chemoradiotheraphy for Extensive Stage Thymic Carcinoma: A Case Report
%A HAFIZ, M.
%A GHANIE ICKSAN, A.
%A ANDARINI, S.
%A HARLIVASARI, A.D.
%J Turk J Oncol
%D 2026
%V 41
%P 160-164
%R 10.5505/tjo.2026.4783